Organic Process Research and Development p. 670 - 685 (2020)
Update date:2022-08-04
Topics:
Hardouin, Christophe
Baillard, Sandrine
Barière, Fran?ois
Craquelin, Anthony
Grandjean, Mathieu
Janvier, Solenn
Le Roux, Stéphane
Penloup, Christine
Russo, Olivier
This paper describes the synthesis of kilogram quantities of the sulfonamide moiety 3 involved in a coupling reaction with acid moiety 2 to provide batches of drug candidate 1 for preclinical studies and first-in-human clinical trials. A first approach relying on a chiral separation furnished the desired enantiomer of 1,3-diamine 20, precursor of sulfonamide 3. An enantiomeric synthesis of 20 using the Ellman's chiral auxiliary coupled with an aza-Reformatsky reaction to control the stereochemistry is also discussed. Coupling conditions of the final step involving EDCI to provide 1 under a cGMP process are detailed. An alternative approach using N-(1-methanesulfonyl)benzotriazole is also presented.
View MoreZhejiang PRIMAR Import & Export Trade Co., Ltd.
Contact:86-570-3630818
Address:No.1Puzhuyuan,Quhua,Zhejiang Province,China324004
Contact:+86-20-62802632;62802633
Address:Room 330 GIGCAS Building,No.511 Kehua Street,Tianhe District
Contact:+86-13914766747
Address:Floors 21&22, Jin Cheng Tower, No. 216 Middle Longpan Road, Nanjing
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
Taizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
Doi:10.1016/j.jorganchem.2008.04.023
(2008)Doi:10.1016/S0040-4039(00)95115-3
(1985)Doi:10.1039/c39860000757
(1986)Doi:10.1002/chem.201501823
(2015)Doi:10.1039/c1gc15701a
(2011)Doi:10.1002/jhet.5570450420
(2008)